DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ advanced 2.14% to $445.04 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.75% to 7,394.30 and the Dow Jones Industrial Average rising 1.86% to 50,848.75.
Vertex Pharmaceuticals Inc. closed 12.38% short of its 52-week high of $507.92, which the company achieved on March 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ fell 0.08% to $224.77, Krystal Biotech Inc. (KRYS) rose 2.92% to $321.55, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 1.16% to $6.97.
Trading volume (1.2 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 11, 2026 16:39 ET (20:39 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.